If Tremfya (Guselkumab) Isn't Approved by UnitedHealthcare in Georgia: Formulary Alternatives & Exception Paths
Answer Box: Tremfya Alternatives & Exception Strategy
If UnitedHealthcare denies Tremfya (guselkumab) in Georgia, you have three main paths: try a formulary-preferred biologic first (often adalimumab or secukinumab), request a step therapy exception with clinical documentation, or appeal through Georgia's external review process within 60 days. Start by